INFORMATION CONTAINED IN THIS FORM 6-K REPORT
On December 28, 2023, SHL Telemedicine Ltd. (the “Company”) announced that the 2023 Annual General Meeting of Shareholders of the Company (the “Annual General Meeting”) will be held on Thursday, February 8, 2024, at 5:00 p.m., Israel time, at the offices of the Company at Ashdar Building — 2nd Floor, 90 Yigal Alon Street, Tel Aviv, Israel, and published its Proxy Statement in connection with the Annual General Meeting. The Notice of Annual General Meeting of Shareholders and the Proxy Statement in connection with the Annual General Meeting are attached hereto as Exhibit 99.1 and are incorporated herein by reference.
A copy of the Voting Instruction Form for holders of the Company’s American Depositary Shares (“ADSs”) being distributed by The Bank of New York Mellon, the Depositary for the Company’s ADS program, is attached hereto as Exhibit 99.2 and is incorporated herein by reference.
A form of Voting Ballot for holders of the Company’s ordinary shares is attached hereto as Exhibit 99.3 and is incorporated herein by reference.
This Report on Form 6-K, including the Notice for the Annual General Meeting, the Proxy Statement, the Voting Instruction Form for holders of the Company’s ADSs and the form of Voting Ballot for holders of the Company’s ordinary shares attached to this Report on Form 6-K, will also be made available on the Company’s corporate website at www.shl-telemedicine.com. Information contained on, or that can be accessed through, the Company’s website, does not constitute a part of this Report on Form 6-K, nor does it form part of the proxy solicitation materials in connection with the Annual General Meeting. The Company has included its website address in this Report on Form 6-K solely as an inactive textual reference. The Company will post on its website any materials in connection with the Annual General Meeting required to be posted on such website under applicable corporate or securities laws and regulations.
